论文部分内容阅读
目的 :探索 2周康复程序对急性心肌梗塞溶栓患者早期康复治疗的安全、有效性。方法 :根据个体化及活动量循序递增的原则 ,对 2 3例急性心肌梗塞重组链激酶 (r- SK)静脉溶栓患者和 2 3例急性心肌梗塞无严重并发症常规治疗患者均进行 2周程序的康复治疗。结果 :r- SK溶栓组的再通率为78.2 6 % ,死亡率和并发症低于非溶栓组 (P<0 .0 5) ,正常进入康复程序的患者多于非溶栓组 (P<0 .0 5) ,住院天数也短于非溶栓组 (分别为 13.2 2± 6 .0 7、 14.2 6± 6 .4 5天 )。康复运动中无一例出现严重合并症。结论 :2周康复程序是安全、有效的 ,而且溶栓配合康复治疗效果更明显。
Objective: To explore the safety and efficacy of 2-week rehabilitation program for early rehabilitation of patients with thrombolytic therapy of acute myocardial infarction. Methods: According to the principle of increasing individuality and activity incrementally, 23 patients with thrombolytic therapy of acute myocardial infarction with recombinant streptokinase (r-SK) and 23 patients with conventional therapy without severe complications of acute myocardial infarction were treated for 2 weeks Rehabilitation program. Results: The recanalization rate of r-SK thrombolysis group was 78.2 6%, the mortality and complications were lower than those of non-thrombolytic group (P <0.05) P <0.05), and hospital stay was also shorter than that in the non-thrombolytic group (13.2 2 ± 6.07, 14.2 6 ± 6.54 days, respectively). No case of serious complications in rehabilitation exercise. Conclusion: The 2-week rehabilitation program is safe and effective, and the effect of thrombolytic therapy combined with rehabilitation is more obvious.